Milan, March 10th, 2022 – Dedalus Group ("Dedalus"), the leading healthcare and diagnostic software solutions provider in Europe, and Ibex Medical Analytics (“Ibex”), the market leader in artificial intelligence (AI)-powered cancer...

Visiopharm has announced preregistration for their USCAP 2022 seminar. AI-driven stain quality standardization of IHC Featuring Marilyn M. Bui, MD, Ph.D., Moffitt Cancer Center and Martin Kristensson, Visiopharm Wednesday, March 23rd,...

AIRA Matrix invites you to the 111th USCAP Annual Meeting, Los Angeles where we exhibit our novel Prostate Cancer Decision Support Suite from 21-23 March 2022. The suite comprising diagnostic, prognostic, and predictive solutions provides...

Join Deep Bio at USCAP 2022 We are excited to finally meet you in person at USCAP 2022! Explore how Deep Bio’s AI solutions have shaped digital pathology. Learn about the new insights from our studies. Deep Bio will be exhibiting...

AIRA Matrix has published a new paper. Read on to learn more about their work. Our paper “A deep learning system for prostate cancer diagnosis and grading in whole slide images of core needle biopsies” has been published in the March...

Proscia and Hamamatsu: Cooperation agreement expands access to unified solution for end-to-end workflow PHILADELPHIA – March 9, 2022 – Proscia®, the leader in digital and computational pathology solutions, and Hamamatsu Photonics K.K.,...